Trial Profile
The study of olanzapine plus fluoxetine in combination for treatment-resistant depression without psychotic features.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Apr 2009
Price :
$35
*
At a glance
- Drugs Olanzapine/fluoxetine (Primary) ; Fluoxetine; Olanzapine
- Indications Depression; Major depressive disorder
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 11 Oct 2006 New trial record.